Published in Pharma Investments, Ventures and Law Weekly, August 7th, 2005
The Chinese patent is the eighth such patent Sutura has received for the company's main SuperStitch technology.
Sutura, Inc. announced on November 22, 2004, that it had signed an Agreement and Plan of Merger with Technology Visions Group, Inc. (TVGR) of San Marcos, California. The merger is now proceeding through due diligence and satisfaction of closing conditions.
Sutura, Inc. is a medical device company that has developed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.